4//SEC Filing
Alkermes plc. 4
Accession 0001127602-15-028806
$ALKSCIK 0001520262operating
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 5:37 PM ET
Size
8.7 KB
Accession
0001127602-15-028806
Insider Transaction Report
Form 4
Alkermes plc.ALKS
Peterson Rebecca
SVP, Corporate Communications
Transactions
- Award
Ordinary Shares
2015-10-05+5,000→ 5,000 total - Tax Payment
Ordinary Shares
2015-10-05$59.77/sh−2,356$140,818→ 2,644 total - Award
Performance Restricted Stock Units
2015-10-05+5,000→ 5,000 total→ Ordinary Shares (5,000 underlying)
Footnotes (2)
- [F1]Each performance restricted stock unit represents a contingent right to receive one ordinary share of Alkermes plc.
- [F2]Represents the earned but unvested portion of the performance restricted stock units granted to the reporting person on March 3, 2014. Fifty percent of the earned performance restricted stock units vested on October 5, 2015 and are included in Table I of this Form 4; the remaining fifty percent of the earned performance restricted stock units are included in Table II of this Form 4 and will vest on October 5, 2016. The performance restricted stock units were earned based on the Food and Drug Administration's approval of ARISTADA? (aripiprazole lauroxil).
Documents
Issuer
Alkermes plc.
CIK 0001520262
Entity typeoperating
Related Parties
1- filerCIK 0001520262
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 5:37 PM ET
- Size
- 8.7 KB